- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 368,659,889
- Total 13F shares
- 24,613,241
- Share change
- +24,613,241
- Total reported value
- $1,036,097,000
- Price per share
- $42.56
- Number of holders
- 76
- Value change
- +$1,036,097,000
- Number of buys
- 76
Quarterly Holders Quick Answers
What is CUSIP 52490G102?
CUSIP 52490G102 identifies LEGN - Legend Biotech Corp - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2020
Recent filing periods for CUSIP 52490G102:
Top shareholders of LEGN - Legend Biotech Corp - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q2 2020
As of 30 Jun 2020,
Legend Biotech Corp - Ordinary Shares (LEGN) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,613,241 shares.
The largest 10 holders included
Vivo Capital, LLC, Hudson Bay Capital Management LP, RA CAPITAL MANAGEMENT, L.P., CAPITAL INTERNATIONAL INC, Johnson & Johnson Innovation - JJDC, Inc., MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ALLIANCEBERNSTEIN L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and Capital International Investors.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q4 2025 Across Filers
Q4 2025 holders
196
Q2 2020 holders
76
Holder diff
-120
| Investor | Q4 2025 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.